{"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"groups":[{"description":"Patients received Daratumumab subcutaneously (fixed dose of 1800 mg) or intravenously (16 mg/kg) weekly for cycles 1-2, every 2 weeks for cycles 3-6, and every 4 weeks thereafter. Pomalidomide was administered at a dose of 4 mg orally every day on days 1 through 21, and dexamethasone at 40 mg (or 20 mg for patients ≥75 years of age) orally weekly, in 28-day cycles..\n\nPomalidomide: Pomalidomide will be administered at full dose of 4 mg orally (PO) on Days 1 through 21 of each 28-day cycle.\n\nDexamethasone: Dexamethasone will be administered at a dose of 40 mg (20 mg for patients ≥75 years of age) orally, once daily on Days 1, 8, 15, and 22 of each 28-day treatment cycle.","id":"BG000","title":"Daratumumab+Pomalidomide+Dexamethasone"},{"description":"Patients received Pomalidomide at a dose of 4 mg orally every day on days 1 through 21, and dexamethasone 40 mg (or 20 mg for patients ≥75 years of age) orally weekly, in 28-day cycles","id":"BG001","title":"Pomalidomide + Dexamethasone"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.57","value":"65.4"},{"groupId":"BG001","spread":"9.70","value":"66.5"},{"groupId":"BG002","spread":"9.63","value":"66.0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"72"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"143"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"79"},{"groupId":"BG001","value":"82"},{"groupId":"BG002","value":"161"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Race and Ethnicity were not collected from any participant.","title":"Race and Ethnicity Not Collected","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"53"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"97"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Greece"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Netherlands"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"40"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Turkey"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"16"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Belgium"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"10"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Czechia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Denmark"},{"categories":[{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"39"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Italy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Serbia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"15"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Germany"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"37"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"Poland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"28"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"France"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"68"},{"groupId":"BG001","value":"69"},{"groupId":"BG002","value":"137"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"I"},{"categories":[{"measurements":[{"groupId":"BG000","value":"50"},{"groupId":"BG001","value":"51"},{"groupId":"BG002","value":"101"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"II"},{"categories":[{"measurements":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"66"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"III"}],"description":"The International Staging System (ISS) consists of the following 3 stages; Stage I: serum beta2-microglobulin less than (\\<) 3.5 milligram per liter (mg/L) and albumin greater than or equal to (≥) 3.5 gram per 100 Milliliter (g/100 mL); Stage II: neither stage I nor stage III; and Stage III: serum beta2-microglobulin greater than or equal to (≥) 5.5 mg/L. Higher stages indicate more severe disease (i.e. worse outcomes).","paramType":"COUNT_OF_PARTICIPANTS","title":"Stage of Disease (ISS)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"34"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"114"},{"groupId":"BG001","value":"113"},{"groupId":"BG002","value":"227"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"2-3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"43"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"153"},{"groupId":"BG002","value":"304"}],"units":"Participants"}],"title":"≥4"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"No. of Prior Lines of Therapy","unitOfMeasure":"Participants"}]}